

Can't find Alitretinoin (Panretin Gel) at your pharmacy? Here are practical tools and tips to help you locate it in stock near you in 2026.
If your pharmacist just told you they can't get Alitretinoin — better known as Panretin Gel — you're dealing with a problem that thousands of patients face every day. This specialty medication for AIDS-related Kaposi sarcoma has been in short supply due to ongoing manufacturing disruptions, and finding it takes more than just calling your local drugstore.
But don't lose hope. With the right approach and the right tools, you can improve your chances of getting your prescription filled. Here's how.
The most efficient way to find Alitretinoin is to stop guessing and start searching strategically. Medfinder is a free tool that helps you locate pharmacies near you that actually have your medication in stock.
Instead of spending hours calling pharmacies one by one, Medfinder lets you search in seconds. This is especially valuable for a medication like Panretin Gel, which costs $6,000 to $7,500 per tube and isn't stocked by most retail pharmacies under normal conditions — let alone during a shortage.
For a detailed walkthrough, see our guide on how to check if a pharmacy has Alitretinoin in stock.
When the big chains are out, independent pharmacies can sometimes come through. Here's why:
Don't overlook hospital outpatient pharmacies, either. If you're being treated at a cancer center or an HIV clinic, their in-house pharmacy may have access to supply that retail pharmacies don't.
Supply chain logistics mean that pharmacies often receive new shipments on specific days. Here are some timing strategies:
If you've tried all of the above and still can't locate Panretin Gel, here are additional steps to consider:
Your oncologist or dermatologist may be aware of supply channels you don't have access to. They can also contact the manufacturer directly or submit a request through specialty pharmacy networks. Some providers have been able to obtain the EU-labeled Panretin that the FDA authorized for US sale in late 2025.
Eisai, the US distributor of Panretin, offers a Patient Assistance Program. While this is primarily designed for patients who can't afford the medication, the program can also help connect you with available supply. Call them directly and explain your situation.
If Alitretinoin remains unavailable for an extended period, your doctor may recommend alternative treatments for your Kaposi sarcoma lesions. Options may include intralesional Vinblastine, topical Imiquimod (Aldara), or topical Timolol. Read our full guide on alternatives to Alitretinoin to learn more about each option.
If you're only searching pharmacies in your immediate area, consider widening your radius. Specialty pharmacies that ship nationwide may have stock when local pharmacies don't. Many specialty pharmacies offer overnight or two-day shipping with cold chain handling as needed.
Finding Alitretinoin is only half the battle — affording it is the other half. With a cash price of $6,000 to $7,500 for a single 60-gram tube, even insured patients can face significant out-of-pocket costs. Discount cards from GoodRx and SingleCare can bring the price down to around $5,950, but that's still a major expense.
We've put together a detailed guide on how to save money on Alitretinoin that covers coupons, patient assistance programs, and insurance strategies.
Finding Alitretinoin in 2026 requires patience, persistence, and the right tools. The shortage is real, but so are the solutions. Start with Medfinder to check real-time pharmacy availability, work with your healthcare team, and don't be afraid to explore specialty pharmacies and patient assistance programs.
For more context on why this shortage is happening, read our post on why Alitretinoin is so hard to find in 2026.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.